Abiopharma

News list

Gorman Andrew 🟡 adjusted position in 2.9K shares of BRADY CORP (BRC) at $90.69 Transaction Date: Sep 01, 2026 | Filing ID: 000004

Full text

News bot Sept. 2, 2026, 3:49 p.m.
🔍 Gorman Andrew (Executive)

Company: BRADY CORP (BRC)

Report Date: 2026-09-01
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 5,389
- Total shares sold: 2,532
Detailed Transactions and Holdings:
- Acquired 5,389 shares of Class A Common Stock (Direct)
  Date: 2026-09-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 20,595.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 2,532 shares of Class A Common Stock at $90.69 per share (Direct)
  Date: 2026-09-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 18,063.00 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: Represents restricted stock units which vested upon achievement of certain financial performance goals over a three-year period. Each restricted stock unit was settled solely by delivery of one share of Class A Common Stock.
- F2: Represents shares withheld to cover taxes on 5,389 restricted stock units that vested on September 1, 2026.